Number of the records: 1  

Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action

  1. 1.
    0454119 - ÚEB 2016 RIV US eng J - Journal Article
    Mrozek-Wilczkiewicz, A. - Spaczynska, E. - Malarz, K. - Cieslik, W. - Rams-Baron, M. - Kryštof, Vladimír - Musiol, R.
    Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action.
    PLoS ONE. Roč. 10, č. 11 (2015), e0142678. ISSN 1932-6203. E-ISSN 1932-6203
    R&D Projects: GA MŠMT(CZ) LO1204
    Institutional support: RVO:61389030
    Keywords : BIOLOGICAL-ACTIVITY SPECTRUM * MUTANT P53 * QUINOLINE DERIVATIVES
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 3.057, year: 2015

    A group of styrylquinolines were synthesized and tested for their anti-proliferative activity. Anti-proliferative activity was evaluated against the human colon carcinoma cell lines that had a normal expression of the p53 protein (HCT116 p53(+/+)) and mutants with a disabled TP53 gene (HCT116 p53(-/-)) and against the GM 07492 normal human fibroblast cell line. A SAR study revealed the importance of Cl and OH as substituents in the styryl moiety. Several of the compounds that were tested were found to have a marked anti-proliferative activity that was similar to or better than doxorubicin and were more active against the p53 null than the wild type cells. The cellular localization tests and caspase activity assays suggest a mechanism of action through the mitochondrial pathway of apoptosis in a p53-independent manner. The activity of the styrylquinoline compounds may be associated with their DNA intercalating ability.
    Permanent Link: http://hdl.handle.net/11104/0254975

     
    FileDownloadSizeCommentaryVersionAccess
    2015_Mrozek-Wilczkiewicz_PLOS ONE_e0142678.pdf01.1 MBOtheropen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.